Heart disease in cattle: diagnosis, therapeutic approaches and prognosis

Sébastien Buczinski1, Ali Rezakhani, Derek Boerboom

  • 1Département des Sciences Cliniques, Université de Montréal, Saint-Hyacinthe, Qc, Canada. s.buczinski@umontreal.ca

Insights

Diagnosing and treating heart disease in cattle is difficult due to its rarity and poor prognosis. This review covers key bovine heart conditions, focusing on evidence-based diagnosis, prognosis, and treatment.

Area of Science:

  • Veterinary Medicine
  • Cardiology
  • Bovine Health

Background:

  • Heart disease presents significant diagnostic and therapeutic challenges in cattle.
  • Low incidence and guarded to poor prognoses contribute to the complexity of bovine cardiac conditions.
  • Existing literature primarily consists of case studies and reports.

Purpose of the Study:

  • To review evidence-based medicine regarding principal heart diseases in cattle.
  • To emphasize diagnosis, prognosis, and treatment strategies for common bovine cardiac conditions.
  • To consolidate current knowledge on bovine heart disease for improved clinical management.

Main Methods:

  • Systematic review of evidence-based literature on bovine heart disease.
  • Focus on key conditions: pericarditis, bacterial endocarditis, congenital heart defects, cor pulmonale, dilated cardiomyopathy, and heart neoplasms.
  • Analysis of diagnostic methods, prognostic indicators, and treatment options.

Main Results:

  • Pericarditis, bacterial endocarditis, congenital defects, cor pulmonale, dilated cardiomyopathy, and neoplasms are principal bovine heart diseases.
  • Diagnosis often relies on clinical signs, auscultation, and diagnostic imaging, with varying success rates.
  • Treatment outcomes are generally guarded, with prognosis dependent on the specific condition and stage.

Conclusions:

  • Evidence-based approaches are crucial for managing heart disease in cattle.
  • Improved diagnostic techniques and treatment protocols are needed to enhance outcomes.
  • Further research is warranted to better understand and address bovine cardiac pathologies.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...